2024 was a record year for obesity trials and 2025 is already poised to take over
The popularity of GLP-1R drugs has catapulted the treatment landscape of obesity into the spotlight....
The popularity of GLP-1R drugs has catapulted the treatment landscape of obesity into the spotlight....
Dorota Grejner-Brzezinska wasn’t looking for a new job when a search firm asked if she’d be interested in leading research at the University of Wisconsin-Madison....
Product approvals in regenerative medicine and rare diseases are among the highlights in our recap of recent FDA regulatory decisions....
Quantum computing and biotech companies are testing whether next-generation computing technology could help them develop better drugs and cut the time and cost of finding new ones....
For the first time in nearly two decades, the University of Wisconsin-Madison’s medical school will have a new leader....
From GLP-1RA and HIV PrEP successes, to flops in DMD and Alzheimer’s, Clinical Trials Arena rounds up the biggest trial read outs of 2024....
One major way AI is set to revolutionize clinical trials is by automating patient recruitment, which is typically the most time-consuming part of a clinical trial....
More than 100 clinical trials put stem cells for regenerative medicine to the test. It’s a turning point for a field beset with ethical and political controversy....
UW Health’s new Eastpark Medical Center has seen an average of 1,000 patients a day in the month since it opened, an immediate wave of demand that reinforces the clinic’s goal of addressing a regional need, a top official says....
Four key predictions for the future of clinical trials, examining how these changes will revolutionize the speed, efficiency, and reliability of bringing life-saving treatments to market....